SERA

Sera Prognostics (SERA)

About Sera Prognostics (SERA)

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Details

Daily high

$3.70

Daily low

$3.38

Price at open

$3.51

52 Week High

$9.13

52 Week Low

$1.37

Market cap

138.6M

Dividend yield

0.00%

Volume

86,025

Avg. volume

52,992

P/E ratio

-4.66

Sera Prognostics News